Pharmacodynamic biomarkers in metronomic chemotherapy: multiplex cytokine measurements in gastrointestinal cancer patients

Metronomic chemotherapy has shown promising antitumor activity in a number of malignancies. We previously reported a phase II clinical trial of metronomic UFT (a 5-fluorouracil prodrug; 100 mg/twice per day p.o.) and cyclophosphamide (CTX; 500 mg/m(2) i.v. bolus on day 1 and then 50 mg/day p.o.) plu...

Full description

Saved in:
Bibliographic Details
Published in:Clin Exp Med
Main Authors: Valenzuela, Paloma, Oaxaca, Derrick, Desidero, Teresa Di, Parra, Karla, Rodriguez, Georgialina, Manciu, Marian, Allegrini, Giacomo, Falcone, Alfredo, Bocci, Guido, Kirken, Robert A., Francia, Giulio
Format: Artigo
Language:Inglês
Published: 2020
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8006211/
https://ncbi.nlm.nih.gov/pubmed/33048259
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10238-020-00666-9
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items